Perceptive Advisors LLC 13D and 13G filings for Verrica Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:30 pm Sale | 2025-03-31 | 13G | VERRICA PHARMACEUTICALS INC VRCA | Perceptive Advisors LLC | 148,148 1.600% | -324,967 (-68.69%) | Filing |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | VERRICA PHARMACEUTICALS INC VRCA | Perceptive Advisors LLC | 473,115 5.100% | -323,100 (-40.58%) | Filing |
| 2024-12-09 6:22 pm Purchase | 2024-12-05 | 13G | VERRICA PHARMACEUTICALS INC VRCA | Perceptive Advisors LLC | 796,215 8.700% | 86,297 (+12.16%) | Filing |
| 2024-02-14 4:47 pm Purchase | 2023-12-31 | 13G | VERRICA PHARMACEUTICALS INC VRCA | Perceptive Advisors LLC | 709,918 16.900% | 206,020 (+40.89%) | Filing |
| 2023-02-14 2:37 pm Purchase | 2022-12-31 | 13G | VERRICA PHARMACEUTICALS INC VRCA | Perceptive Advisors LLC | 503,898 12.300% | 142,857 (+39.57%) | Filing |
| 2022-02-14 3:54 pm Purchase | 2021-12-31 | 13G | VERRICA PHARMACEUTICALS INC VRCA | Perceptive Advisors LLC | 361,041 13.100% | 20,000 (+5.86%) | Filing |